長安汽車(000625.SZ):已售寧德時代2299.96萬股 影響2020年度税後淨利潤19.71億元
格隆匯 10 月 30日丨長安汽車(000625.SZ)公佈,2020年7月1日至10月30日,公司通過集中競價的方式累計出售寧德時代2299.9575萬股,佔其當前總股本的0.99%,累計成交金額42.59億元。
預計扣除成本和相關税費後,上述交易影響公司2020年度税後淨利潤約19.71億元。以上數據為初步核算數據,公司將根據《企業會計準則》等有關規定對投資收益進行會計處理,具體以會計師年度審計結果為準。
截至公告日,公司不再持有寧德時代股票。此次減持不會影響長安汽車與寧德時代的戰略合作,雙方將全面深入推進在智能網聯電動汽車領域的合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.